2,914 material Form 8-K filings that 2,352 companies we cover made with the SEC in August 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Wheels Up Experience said its Chief Sales Officer, Mark Briffa, will leave the role and remain with the company to transition his duties through September 1, 2026. David Godsman, the Chief Digital Officer, will lead the global sales organization on an interim basis, and a settlement agreement dated August 12, 2026 sets out Briffa's separation payments and equity treatment.
Briffa agreed on August 10, 2026 to depart as Chief Sales Officer, with his transition running through September 1, 2026.
David Godsman takes interim leadership of global sales in addition to his Chief Digital Officer role.
Settlement agreement with subsidiary Air Partner Limited provides continued salary through December 31, 2026 and severance lump sums totaling £378,354.82, less deductions.
A full-year 2026 bonus is payable in 2027 subject to plan metrics; RSUs and PSUs vest on original schedules through September 1, 2027, and all other equity awards were forfeited.
Jacobs Solutions said its President, Strategy, Growth & Digital, Shannon Miller, transitioned from that role on August 10, 2026, and will serve as Special Advisor to the CEO until she leaves the company, no later than October 3, 2026. The filing gives no successor, financial effect, or reason for the change.
Shannon Miller's role as President, Strategy, Growth & Digital ended with a transition on August 10, 2026.
Miller will serve as Special Advisor to CEO Robert V. Pragada until her departure.
Her departure from the company is due no later than October 3, 2026.
The filing does not name a replacement or disclose compensation terms.
Dave Inc. disclosed that director Yadin Rozov resigned from its Board of Directors, effective immediately, after notifying the company on August 12, 2026. The company said the resignation was for personal reasons and not tied to any disagreement over operations, policies or practices. The filing does not name a replacement, so the board's size and composition after the departure are not stated.
Yadin Rozov notified Dave Inc. of his resignation from the Board on August 12, 2026, effective immediately.
The company states the resignation was for personal reasons and was not related to any disagreement with the company.
The filing does not identify a successor or any replacement director.
Tutor Perini disclosed that William E. Jensen, Executive Vice President - Civil West, notified the company on August 11, 2026 of his decision to retire effective September 4, 2026. The filing does not name a successor or describe any change to compensation, and the company thanked him for his service.
William E. Jensen, Executive Vice President - Civil West, to retire
Applied Industrial Technologies elected Pamela J. Tomczik, currently Senior Vice President, Treasurer and Business Development at Target Corporation, to its Board of Directors effective August 11, 2026. Director Peter C. Wallace submitted his retirement notice the same day under the company's director retirement policy, effective at the October 20, 2026 annual meeting of shareholders.
Pamela J. Tomczik, age 52, elected to the board on August 11, 2026, with a term expiring in October 2026; no committee appointments yet.
Tomczik has served as Senior Vice President, Treasurer and Business Development at Target Corporation since October 2022.
Peter C. Wallace gave notice of retirement from the board on August 11, 2026, under the director age-72 retirement policy, effective October 20, 2026.
Tomczik will receive non-employee director compensation and enter an Indemnification Agreement with Applied.
U.S. Physical Therapy appointed Nchacha Etta as Executive Vice President and Chief Financial Officer, effective September 1, 2026, ending Jason Curtis's role as interim CFO. Etta's employment agreement sets a $625,000 base salary and equity grants of about $550,000 and $200,000, with severance and change-in-control benefits that shareholders may want to note.
Base salary of $625,000 per year, plus discretionary bonuses set by the Board or compensation committee
Initial restricted stock grant of about $550,000 vesting in equal quarterly installments over four years
Change-in-control benefit of $283,333; termination without cause or for good reason triggers two years of base pay plus bonus-related payments
Jason Curtis, SVP Finance and Accounting, stops serving as interim CFO and remains SVP
H&R Block said on August 12, 2026, that directors Robert A. Gerard and Matthew E. Winter will retire and not stand for re-election at the 2026 Annual Meeting in November. The company said their decisions were not due to any disagreement over operations, policies, or practices. Gerard served as Chairman for almost 14 years, and Winter chaired the Compensation Committee.
Robert A. Gerard and Matthew E. Winter notified the Board on August 12, 2026.
Both will remain directors until the 2026 Annual Meeting of Shareholders in November.
Gerard served as Chairman of the Board for almost 14 years; Winter was Chair of the Compensation Committee.
The filing states no disagreement with the company on operations, policies, or practices.
Hawkins, Inc. said director Yi "Faith" Tang resigned from its Board of Directors and all board committees, effective immediately, after notifying the company on August 13, 2026. The filing states her resignation was not due to any disagreement with the company on its operations, policies or practices.
Yi "Faith" Tang resigned from the Board of Directors and its committees.
Notice was given on August 13, 2026; the resignation is effective immediately.
The filing states there was no disagreement relating to company operations, policies or practices.
Cencora director Lorence H. Kim informed the company on August 13, 2026 of his intent to resign from the Board effective immediately. He cited his appointment as Chief Financial Officer of Commonwealth Fusion Systems, Inc. and the need to devote more time to that role, and said the resignation involves no disagreement with the company on its operations, policies or practices.
Resignation from the Board of Directors is effective immediately, informed on August 13, 2026 after the quarterly board meeting.
Dr. Kim cited his appointment as Chief Financial Officer of Commonwealth Fusion Systems, Inc. as the reason.
The filing states there was no disagreement with the company on operations, policies or practices.
Power Integrations said Senior Vice President of Operations Sunil Gupta notified the company on August 11, 2026 of his intent to resign, effective August 25, 2026. The company said the resignation did not result from any disagreement over its operations, policies, or practices.
Sunil Gupta, Senior Vice President, Operations, gave notice of resignation on August 11, 2026
Resignation takes effect August 25, 2026
Company states the departure did not stem from any disagreement on operations, policies, or practices
NewAmsterdam Pharma appointed Robert W. Gunning as its principal accounting officer on August 10, 2026, succeeding Louise Kooij, whose previously announced departure takes effect August 31, 2026. Gunning joined the company as Vice President, Controller on the same day, and his offer letter sets a $375,000 base salary and a 30% target bonus.
Robert W. Gunning, age 55, appointed principal accounting officer on August 10, 2026
Succeeds Louise Kooij, whose departure is effective August 31, 2026
Offer letter dated July 24, 2026: $375,000 base salary, 30% target bonus, 3,200 RSUs and options on 14,000 shares
Previously served as Vice President Finance and Corporate Controller at Y-mAbs Therapeutics from April 2022 to April 2026
On August 10, 2026, Senior Vice President, Operations Jeffrey Zerillo notified Prestige Consumer Healthcare Inc. that he will retire from that role and all other positions he holds with the company, effective August 14, 2026. The filing does not name a successor or describe any separation or compensation terms, so shareholders have limited information on how the operations role will be filled.
Retirement notice given August 10, 2026
Retirement effective August 14, 2026, covering the SVP Operations role and all other positions held
Filing signed by Christine Sacco, Chief Financial Officer and Chief Operating Officer
No successor or separation terms disclosed in the filing
Mastech Digital, Inc. granted its Chief Financial and Operations Officer, Kannan Sugantharaman, 20,000 restricted stock units on August 10, 2026. The units vest in three installments over three years, which ties part of his compensation to continued service and to the company's share price.
Award of 20,000 restricted stock units dated August 10, 2026
Vesting: 6,667 units at one year, 6,667 at two years, and 6,666 at three years
Terms are set out in a Restricted Stock Unit Agreement, filed as Exhibit 10.1
Farmer Mac appointed Nader Pasdar as Executive Vice President and Chief Business Officer and Robert J. Maines as Executive Vice President and Chief Operations Officer, both effective August 17, 2026. Pasdar joins from Rabobank, where he was CEO of Rabo Securities, and Maines's salary rises to $440,000, so the changes reshape the senior leadership team that reports to CEO Zachary Carpenter.
Nader Pasdar becomes Executive Vice President and Chief Business Officer on August 17, 2026, reporting to CEO Zachary Carpenter.
Pasdar previously served as CEO of Rabo Securities and Managing Director, Head of Markets North America for Rabobank.
Robert J. Maines, age 58, becomes Executive Vice President and Chief Operations Officer effective August 17, 2026, with an annual salary of $440,000.
Maines will be considered for 2027 long-term equity incentive grants with a target value of not less than $225,000.
Labcorp said executive Megan D. Bailey will resign as Executive Vice President and President, Central Laboratories and International, effective September 4, 2026. Brian J. Caveney, M.D., currently President of Early Development Research Laboratories and Chief Medical and Scientific Officer, will take a broader role effective September 1, 2026, overseeing Biopharma Laboratory Services along with the Early Development Research Laboratories and Central Laboratories businesses.
Megan D. Bailey notified the company of her resignation on August 11, 2026, effective September 4, 2026
Brian J. Caveney, M.D., takes on expanded role effective September 1, 2026
Caveney's new title: EVP and President, Biopharma Laboratory Services and Chief Medical and Scientific Officer
The filing does not state a replacement for Bailey's former role or any financial terms
Sotera Health director James C. Neary resigned from the board as a Class I director, effective August 13, 2026, after notifying the board on August 11, 2026. The company says the resignation was not due to any disagreement over operations, policies or practices, and the board reduced its size to eleven directors.
James C. Neary resigned as a Class I director, effective August 13, 2026
Notice of resignation given to the board on August 11, 2026
Company states no disagreement with management on operations, policies or practices
Board size fixed at eleven directors as of the effective date
Neumora reported a second-quarter 2026 net loss of $43.1 million, down from $52.7 million a year earlier, as research and development and general and administrative expenses declined. On the same day, President Joshua Pinto became chief executive officer effective August 14, 2026, succeeding Paul L. Berns, who becomes Executive Chairperson. The company said its $116.8 million in cash and cash equivalents is expected to support operations into the third quarter of 2027.
Q2 2026 net loss was $43.1 million, compared with $52.7 million in Q2 2025.
R&D expense was $29.3 million (Q2 2025: $38.7 million); G&A expense was $12.9 million (Q2 2025: $15.3 million).
Joshua Pinto, Ph.D., succeeds Paul L. Berns as CEO effective August 14, 2026, and was appointed a Class III director.
Cash and cash equivalents were $116.8 million as of June 30, 2026, expected to fund operations into the third quarter of 2027.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.